SCHEMBL3658339

SCHEMBL3658339

Cc1cc(NC(=O)c2cccnc2)ccc1[N+]1(C2CCNC2)CCCC1C

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.52
NPC1 O15118 8/20 0.49
SMN1; SMN2 Q16637 6/20 0.45
MAPT P10636 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
GAA P10253 1/20 0.43
LDLR P01130 1/20 0.43
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
TP53 P04637 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
KCNK3 O14649 1/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3656228 0.94 RAB9A (0.46) RAB9ANPC1SMN1; SMN2MAPTTDP1
SCHEMBL3653079 0.87 RAB9A (0.50) RAB9ANPC1SMN1; SMN2MAPTTDP1
SCHEMBL3650124 0.84 HSP90AA1 (0.50) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL3655641 0.84 MAPK14 (0.44) RAB9ANPC1SMN1; SMN2MAPTTDP1
SCHEMBL3655153 0.84 NPC1 (0.43) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL3657580 0.84 ESR1 (0.46) RAB9AMAPTMEN1KMT2AKCNK3
SCHEMBL3652477 0.83 ESR1 (0.45) RAB9ANPC1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL3652245 0.82 NPC1 (0.39) RAB9ANPC1SMN1; SMN2MAPTMEN1
Trifluoroacetic Acid SCHEMBL3653109 0.82 RAB9A (0.45) RAB9ANPC1SMN1; SMN2MAPTGAA
Trifluoroacetic Acid SCHEMBL3657556 0.80 HSP90AA1 (0.45) RAB9ANPC1SMN1; SMN2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212282-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052065-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed